AXA/2025/FY/Earnings presentation: Difference between revisions
Content deleted Content added
PlumBot: publish from draft |
PlumBot: publish from draft |
||
Line 17:
== Front matter ==
=== Full Year 2025
* '''
=== IMPORTANTLEGALINFORMATIONANDCAUTIONARYSTATEMENTSCONCERNINGFORWARD-LOOKINGSTATEMENTSANDTHEUSEOF NON-GAAPFINANCIALMEASURES ===
* '''Forward-looking statements''' include predictions
* '''
* '''
* '''APM reconciliations''' are provided in AXA's Activity Report as of December 31, 2025, available on www.axa.com <sup>p. 2</sup>.
* '''Financial statements''' for the year ended December 31, 2025 were examined by the Board of Directors on February 25, 2026, and are subject to
=== Table of contents ===
* '''FY25 Highlights''' presented by Thomas Buberl, Group CEO
* '''FY25 Business Performance''' presented by Guillaume Borie, Global Head of Finance, Strategy, Underwriting, Risk, and Technology
* '''FY25 Financial Performance''' presented by Alban de Mailly Nesle, Group CFO
== FY25 Highlights ==
* '''Section
=== Full Year 2025 | Excellent performance ===
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ Key financial highlights, FY25 <sup>p. 5</sup>
! style="text-align:left" | Metric
! class="col-
! class="col-s" style="text-align:right" | Change vs. FY24
|-
| style="text-align:left" | Revenues
|
| style="text-align:right" | +6%
|-
| style="text-align:left" | Underlying EPS
|
| style="text-align:right" | +8%
|-
| style="text-align:left" | Return on equity
|
| style="text-align:right" | —
|-
| style="text-align:left" | Solvency II ratio
|
| style="text-align:right" | —
|}
</div>
* Shareholder value delivered via +8% DPS growth and EUR 1.25bn annual share buyback
** Dividend proposal based on Board of Directors' recommendation on February 25, 2026, subject to approval at the Shareholders' Annual General Meeting on April 30, 2026
** Share buyback approved by the Board of Directors on February 25, 2026, expected to commence as soon as reasonably practicable, subject to market conditions
* Underlying EPS growth target for 2026 expected at the upper end of the 6%-8% range
=== Executing the plan on growth, margin and efficiency ===
Line 71 ⟶ 74:
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ Underlying earnings and growth, FY24 vs FY25 <sup>p. 6</sup>
! style="text-align:left" | EUR billion unless otherwise mentioned
! class="col-s" style="text-align:right" | FY24
Line 85 ⟶ 88:
|}
</div>
*
* Record profitability driven by further margin expansion in P&C and L&H, alongside improvement in efficiency
* Scaling the business through continued investments in growth and technology
*
=== Diversified franchise, well positioned in an attractive industry ===
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ Business mix based on FY25 gross written premium split <sup>p. 7</sup>
! style="text-align:left" | Segment
! class="col-s" style="text-align:right" | Share
|-
Line 114 ⟶ 117:
|}
</div>
* '''Secular trends''' are fueling demand across businesses, driven by protection gaps, emerging corporate risks, and demographics driving demand for private retirement and healthcare.
* '''Our right to win''' is supported by four key pillars:
** Leading brand & high customer NPS
** Strong and diversified distribution
** Technical expertise to price & underwrite risks
** Scale offering cost advantage
=== Laying the foundation for the next plan ===
Line 128 ⟶ 132:
** '''Enhancing capital allocation''' discipline <sup>p. 8</sup>
** '''Building resilience''' <sup>p. 8</sup>
* '''Earnings growth outlook'''
=== FY25 Business Performance ===
* '''Section
== FY25 Business Performance ==
=== Strong delivery across our businesses ===
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ Gross written premiums and underlying earnings by region <sup>p. 10</sup>
! style="text-align:left" | EUR billion unless otherwise mentioned
! class="col-
! class="col-
! class="col-
! class="col-s" style="text-align:right" | Underlying earnings
! class="col-s" style="text-align:right" | Underlying earnings change
|-
| style="text-align:left" | France
|
|
|
| style="text-align:right" | 2.2
| style="text-align:right" | +7%
|-
| style="text-align:left" | Europe
|
|
|
| style="text-align:right" | 3.5
| style="text-align:right" | +9%
|-
| style="text-align:left" | AXA XL
|
|
|
| style="text-align:right" | 1.9
| style="text-align:right" | +9%
|-
| style="text-align:left" | Asia, Africa & EME-LATAM
|
|
|
| style="text-align:right" | 1.5
| style="text-align:right" | +6%
|}
</div>
* '''Gross written premiums''' change is at constant scope and FX
* '''Underlying earnings''' change is at constant FX
* '''Total GWP''' basis excludes AXA IM, Holdings, AXA Assistance, and AXA Liabilities Managers for FY25 gross written premiums
=== P&C | Strong margins, confidence in sustaining growth ===
<div style="overflow-x:auto">
{| class="wikitable fintable"
! style="text-align:left" | Segment
! class="col-s" style="text-align:right" | Share
|-
| style="text-align:left" | Retail
| style="text-align:right" | 34%
|-
| style="text-align:left" | AXA XL (Large & Specialty)
| style="text-align:right" | 33%
|-
| style="text-align:left" | SME & Mid-market
| style="text-align:right" | 33%
|}
</div>
* '''Underlying earnings''' +9% LFL to EUR 5.9bn
* '''AXA XL''' includes AXA XL Re premiums of EUR 2.6bn
* '''Retail and SME & Mid-market''' strategic outlook:
** '''2025''': Growing volumes while expanding margins
** '''Beyond 2025''': Investing to improve customer retention and expanding distribution footprint
* '''AXA XL (Large & Specialty)''' strategic outlook:
** '''2025''': Profitable growth with stable margins
** '''Beyond 2025''': Capitalizing on attractive growth opportunities and continued cycle management
* '''Growth enablers''':
** Continued progress on efficiency
** Higher investment income
** Data & AI to further enhance customer experience and technical excellence
* (pie) '''GWP mix''': EUR 58bn total GWP, split across Retail, AXA XL (Large & Specialty), and SME & Mid-market <sup>p. 11</sup>
=== L&H| Good momentum, well positioned to capture growth opportunities ===
<div style="overflow-x:auto">
{| class="wikitable"
|+ GWP mix <sup>p. 12</sup>
! style="text-align:left" | Segment
! class="col-s" style="text-align:right" | Share
|-
| style="text-align:left" | Long-term
| class="col-s" style="text-align:right" | Majority
|-
| style="text-align:left" | Short-term
| class="col-s" style="text-align:right" | Minority
|}
</div>
* Underlying earnings +7% LFL to EUR 3.5bn <sup>p. 12</sup>
* '''Long-term business''' strategic outlook:
** '''2025''': Accelerating net flows in Savings at attractive margins <sup>p. 12</sup>
** '''Beyond 2025''': Capturing savings & retirement opportunity, sourcing best asset management products for our customers <sup>p. 12</sup>
* '''Short-term business''' strategic
** '''2025''': Growing technical results while absorbing Mexico VAT impact <sup>p. 12</sup>
** '''Beyond 2025''': Capitalizing on demand for health & protection while further improving our margins <sup>p. 12</sup>
Line 193 ⟶ 246:
** Increasing penetration of Protection riders in Savings offerings <sup>p. 12</sup>
** Leveraging AI to reduce claims leakage & improve customer outcomes in Health <sup>p. 12</sup>
* (pie) '''GWP mix''': EUR 57bn total, split between Long-term (majority) and Short-term <sup>p. 12</sup>
=== FY25 Financial Performance ===
* '''Section
=== P&C
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ GWP & other revenues by
! style="text-align:left" | EUR billion unless otherwise mentioned
! class="col-s" style="text-align:right" | FY24
Line 241 ⟶ 294:
</div>
*
*
*
*
=== P&C
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ Combined ratio components
! style="text-align:left" | %
! class="col-s" style="text-align:right" | FY24
Line 277 ⟶ 330:
</div>
*
* '''Undiscounted
** Margin expansion in Commercial lines SME & mid-market business and Personal lines reflecting
** Stable AXA XL Insurance margins at attractive levels reflecting disciplined cycle management <sup>p. 15</sup>
* '''Expense ratio''' improved reflecting the impact of efficiency measures, while continuing to invest in growth initiatives and technology <sup>p. 15</sup>
* '''Nat Cat charges'''
* '''Prior year reserve development''' reliance was lower, taking advantage of a good year to enhance reserve prudence <sup>p. 15</sup>
=== P&C
<div style="overflow-x:auto">
Line 296 ⟶ 349:
| style="text-align:right" | 5,510
|-
| style="text-align:left" |
| style="text-align:right" | +292
|-
| style="text-align:left" |
| style="text-align:right" | +189
|-
| style="text-align:left" |
| style="text-align:right" | +435
|-
| style="text-align:left" |
| style="text-align:right" | -235
|-
Line 318 ⟶ 371:
|}
</div>
* '''Underlying earnings''' grew +9% at constant FX to EUR 5,872m.
* '''Underwriting result''' improved from strong volume growth and improved all-year combined ratio while enhancing reserve prudence.
* '''Investment income''' increased reflecting higher volumes and better reinvestment yields on fixed income assets.
* '''Insurance finance expenses''' impacted by higher unwind of discount of claims reserves, in line with guidance.
* '''Forex impact''' was unfavorable, notably due to USD depreciation vs. EUR.
=== Life & Health | Strong growth in premiums, positive net flows ===
Line 328 ⟶ 382:
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ Life GWP & other revenues
! style="text-align:left" | EUR billion unless otherwise mentioned
! class="col-s" style="text-align:right" | FY24
! class="col-s" style="text-align:right" | FY25
! class="col-s" style="text-align:right" | LFL
|-
| style="text-align:left" | Protection
Line 345 ⟶ 392:
| style="text-align:right" | 17.3
| style="text-align:right" | +11%
|-
| style="text-align:left" | Unit-linked
Line 351 ⟶ 397:
| style="text-align:right" | 9.3
| style="text-align:right" | +13%
|-
| style="text-align:left" | Capital light G/A
Line 357 ⟶ 402:
| style="text-align:right" | 9.0
| style="text-align:right" | +7%
|-
| style="text-align:left" | Traditional G/A
Line 363 ⟶ 407:
| style="text-align:right" | 1.9
| style="text-align:right" | -7%
|-
| style="text-align:left; font-weight:bold" |
| style="text-align:right; font-weight:bold" |
| style="text-align:right; font-weight:bold" |
| style="text-align:right; font-weight:bold" | +
|}
</div>
{| class="wikitable fintable"
|+ Health GWP & other revenues, FY24 vs FY25 <sup>p. 17</sup>
! class="col-s" style="text-align:right" | FY24
! class="col-s" style="text-align:right" | FY25
! class="col-s" style="text-align:right" | LFL change
|-
| style="text-align:left" | Individual
Line 381 ⟶ 427:
| style="text-align:right" | 10.5
| style="text-align:right" | +6%
|-
| style="text-align:left" | Group
Line 387 ⟶ 432:
| style="text-align:right" | 8.5
| style="text-align:right" | +4%
|-
| style="text-align:left; font-weight:bold" |
| style="text-align:right; font-weight:bold" |
| style="text-align:right; font-weight:bold" |
| style="text-align:right; font-weight:bold" |
|}
</div>
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ Net flows by segment, FY25 <sup>p. 17</sup>
! style="text-align:left" | EUR billion
! class="col-s" style="text-align:right" | Net flows
|-
| style="text-align:left" | Protection
| style="text-align:right" | +4.9
|-
| style="text-align:left" | Health
| style="text-align:right" | +2.7
|-
| style="text-align:left" | Unit-linked
| style="text-align:right" | +1.5
|-
| style="text-align:left" | Capital light G/A
| style="text-align:right" | +1.2
|-
| style="text-align:left" | Traditional G/A
| style="text-align:right" | -5.0
|}
</div>
* '''Employee Benefits''' GWP and other revenues (including both short-term and long-term) was EUR 12.9bn in FY25, up +4%.
* '''Net flows''' reached EUR +5.4bn (compared to EUR +1.5bn in FY24).
=== Life & Health | Strong volume growth in Savings and Protection impacted by higher interest rates on discounting ===
Line 413 ⟶ 474:
! class="col-s" style="text-align:right" | FY24
! class="col-s" style="text-align:right" | FY25
! class="col-s" style="text-align:right" | LFL
|-
| style="text-align:left" | '''PVEP'''
Line 449 ⟶ 510:
| style="text-align:right" | 2.2
| style="text-align:right" | stable
|-
| style="text-align:left" | NBV margin
| style="text-align:right" | 4.4%
| style="text-align:right" | 4.5%
| style="text-align:right" | —
|}
</div>
*
* '''NB CSM''' was driven by robust Savings & Protection sales, with reported growth impacted by higher interest rates for discounting of future profits.
* '''NBV''' was stable as strong growth in NB CSM balanced lower contribution from short-term multinational business in France.
=== Life & Health | Growth in new business driving Normalized CSM growth ===
Line 460 ⟶ 526:
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ Contractual Service Margin rollforward, FY24 to FY25 <sup>p. 19</sup>
! style="text-align:left" | EUR billion
! class="col-s" style="text-align:right" | Contractual Service Margin
|-
| style="text-align:left" | FY24 starting value
| style="text-align:right" | 33.6
|-
Line 485 ⟶ 551:
| style="text-align:right" | -1.4
|-
| style="text-align:left" | FY25 ending value
| style="text-align:right" | 33.0
|}
</div>
* '''Normalized CSM''' up by +2% LFL, with CSM release growth reflecting better margins and new business CSM growth impacted by higher rates
* '''Economic variance''' reflecting government spreads tightening and positive equity market returns
* '''Operating variance''' driven by better margins and net flows that were more than offset by a reduction in the duration of Group Life business in Switzerland
* '''FX impact''' mainly from JPY and HKD depreciation
* FY24 starting value: o/w Life
* CSM release: Normalized CSM growth +2%
* FY25 ending value: o/w Life EUR 25.4bn, o/w Health EUR 7.6bn
=== Life & Health | Strong momentum in both short-term and long-term business ===
Line 501 ⟶ 568:
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ Underlying earnings bridge, FY24 to FY25 <sup>p. 20</sup>
! style="text-align:left" | EUR million
! class="col-s" style="text-align:right" | Underlying earnings
|-
| style="text-align:left" | FY24 start
| style="text-align:right" | 3,323
|-
Line 520 ⟶ 587:
| style="text-align:right" | -27
|-
| style="text-align:left" | FY25 end
| style="text-align:right" | 3,501
|}
</div>
* '''Underlying earnings'''
* '''Short-term technical margin''': EUR 415m in FY24 to EUR 479m in FY25
* '''Long-term result''' incl. CSM release
* '''Financial result''': EUR 975m in FY24 to EUR 946m in FY25
* '''Tax & others''':
* '''Life segment'''
* '''Health segment'''
* '''Short-term technical margin''' strong
* '''Long-term results''' higher from
=== Growth in net income reflecting higher earnings & the gain from the sale of AXA IM ===
Line 539 ⟶ 606:
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ Earnings and
! style="text-align:left" | EUR billion unless otherwise mentioned
! class="col-s" style="text-align:right" |
! class="col-s" style="text-align:right" |
! class="col-s" style="text-align:right" | Change
|-
| style="text-align:left" | Property & Casualty
Line 572 ⟶ 639:
| style="text-align:left" | Non-financial flows
| style="text-align:right" | -0.5
| style="text-align:right" | +2.1
| style="text-align:right" | —
|-
| style="text-align:left" | Financial flows (
| style="text-align:right" | +0.3
| style="text-align:right" | -0.7
| style="text-align:right" | —
Line 594 ⟶ 656:
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ Underlying earnings per share (reported basis) <sup>p. 21</sup>
! style="text-align:left" |
! class="col-s" style="text-align:right" |
|-
| style="text-align:left" |
| style="text-align:right" | 3.59
|-
| style="text-align:left" | Current year
| style="text-align:right" | 3.86
|-
| style="text-align:left" | Change
| style="text-align:right" | +8%
|-
| style="text-align:left" | Earnings growth contribution
| style="text-align:right" | +6%
|-
| style="text-align:left" | Capital management contribution
| style="text-align:right" | +3%
|-
| style="text-align:left" | Forex impact
| style="text-align:right" | -2%
|-
| style="text-align:left" |
| style="text-align:right" | -1%
|}
</div>
* '''Underlying earnings''' driven by strong performance from insurance businesses
* '''
* '''Net income''' increase mainly reflects higher underlying earnings and the gain from the sale of AXA IM
* '''Non-financial flows''': Capital gains from AXA IM disposal: EUR +2.2bn (prior: nil)
* '''Financial flows''' lower, reflecting unfavorable forex impact
* '''Dilution''' impact: includes -1% from temporary earnings dilution from AXA IM sale due to the timing of the anti-dilutive share buyback
== FY25 Financial Performance ==
=== Shareholders' Equity ===
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ Shareholders' equity and related metrics <sup>p. 22</sup>
! style="text-align:left" | EUR billion unless otherwise mentioned
! class="col-s" style="text-align:right" | FY24
! class="col-s" style="text-align:right" | HY25
! class="col-s" style="text-align:right" | FY25
|-
| style="text-align:right" | 49.9
| style="text-align:right" | 45.5
| style="text-align:right" | 47.2
|-
| style="text-align:left" | SHE excl. OCI
| style="text-align:right" | 58.0
| style="text-align:right" | 52.7
| style="text-align:right" | 54.0
|-
| style="text-align:left" | Net OCI
| style="text-align:right" | -8.1
| style="text-align:right" | -7.2
| style="text-align:right" | -6.8
|-
| style="text-align:left" | SHE (excl. OCI & undated subordinated debt)
| style="text-align:right" | 53.2
| style="text-align:right" | 47.0
| style="text-align:right" | 49.4
|-
| style="text-align:left" | Debt gearing
| style="text-align:right" | 20.6%
| style="text-align:right" | 23.4%
| style="text-align:right" | 22.3%
|-
| style="text-align:left" | Underlying ROE
| style="text-align:right" | 15.2%
| style="text-align:right" | 17.5%
| style="text-align:right" | 16.0%
|}
</div>
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ Shareholders' equity bridge, FY24 to FY25 vs. HY25 to FY25 <sup>p. 22</sup>
! style="text-align:left" | EUR billion
! class="col-s" style="text-align:right" | FY24 to FY25
! class="col-s" style="text-align:right" | HY25 to FY25
|-
| style="text-align:left" | Opening Shareholders' equity
| style="text-align:right" | 49.9
| style="text-align:right" | 45.5
|-
| style="text-align:left" | Change in Net OCI
| style="text-align:right" | +1.3
| style="text-align:right" | +0.4
|-
| style="text-align:left" | Net income for the period
| style="text-align:right" | +9.8
| style="text-align:right" | +5.9
|-
| style="text-align:left" | Dividend
| style="text-align:right" | -4.6
| style="text-align:right" | nil
|-
| style="text-align:left" | Annual share buyback
| style="text-align:right" | -1.2
| style="text-align:right" | nil
|-
| style="text-align:left" | Anti-dilutive share buyback following the sale of AXA IM
| style="text-align:right" | -3.5
| style="text-align:right" | -3.5
|-
| style="text-align:left" | Undated subordinated debt (including interest charges)
| style="text-align:right" | -0.3
| style="text-align:right" | -1.2
|-
| style="text-align:left" | Forex
| style="text-align:right" | -3.5
| style="text-align:right" | -0.1
|-
| style="text-align:left" | Other
| style="text-align:right" | -0.6
| style="text-align:right" | +0.3
|-
| style="text-align:left" | Closing Shareholders' equity
| style="text-align:right" | 47.2
| style="text-align:right" | 47.2
|}
</div>
* '''Shareholders' equity''' (Group share) reported in EUR billion <sup>p. 22</sup>.
=== Higher organic cash remittance and robust cash position at Holding ===
Line 659 ⟶ 788:
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ Net cash remittance and
! style="text-align:left" | EUR billion unless otherwise mentioned
! class="col-s" style="text-align:right" | FY24
! class="col-s" style="text-align:right" | FY25
|-
| style="text-align:left" | Net cash remittance total
| style="text-align:right" | 7.7
| style="text-align:right" | 7.5
|-
| style="text-align:left" | Ordinary remittance
Line 671 ⟶ 804:
| style="text-align:right" | 0.6
| style="text-align:right" | —
|-
| style="text-align:left" | Remittance ratio
Line 684 ⟶ 813:
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ Holding cash position bridge <sup>p. 23</sup>
! style="text-align:left" | EUR billion
! class="col-s" style="text-align:right" |
|-
| style="text-align:left" | FY24
| style="text-align:right" | 4.0
|-
Line 711 ⟶ 841:
| style="text-align:right" | +3.1
|-
| style="text-align:left" | FY25
| style="text-align:right" | 5.6
|}
Line 726 ⟶ 856:
! class="col-s" style="text-align:right" | Eligible Own Funds (EOF)
! class="col-s" style="text-align:right" | Solvency Capital Requirement (SCR)
! class="col-s" style="text-align:right" | Solvency II ratio (
|-
| style="text-align:left" | FY24
Line 769 ⟶ 899:
|}
</div>
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ Key sensitivities
! style="text-align:left" | Sensitivity
! class="col-s" style="text-align:right" | Change (pts)
Line 811 ⟶ 938:
</div>
*
=== Solvency II -impact of the end of grandfathering period and Solvency II revision ===
Line 819 ⟶ 945:
{| class="wikitable fintable"
|+ Solvency II ratio and impacts <sup>p. 25</sup>
! style="text-align:left" |
! class="col-s" style="text-align:right" | Value
|-
| style="text-align:left" |
| style="text-align:right" | 224
|-
| style="text-align:left" | Grandfathering end impact on January 1, 2026
| style="text-align:right" | -
|-
| style="text-align:left" |
| style="text-align:right" |
|-
| style="text-align:left" | Solvency II revision impact (estimated)
| style="text-align:right" | +17
|}
</div>
* EUR 2.4bn of grandfathered debt is no longer eligible as capital from January 1, 2026.
* No change is expected in organic capital generation.
* Provides additional capital flexibility.
* Revision impact is estimated based on the Solvency Capital Requirement (SCR) and the amount of capital (EOF) under Solvency II as of January 1, 2026, as if the Solvency II revision had come into force on the same date.
* '''
=== Thomas Buberl, Group CEO
* '''
=== Conclusion ===
* '''Record results''' achieved at the top end of the target range while enhancing reserve prudence <sup>p. 27</sup>.
* '''
* '''Diversified franchise'''
* '''
=== February 26, 2026 Q&A Full Year 2025
* '''Q&A session''' for Full Year 2025 Earnings held on February 26, 2026 <sup>p. 28</sup>
Line 856 ⟶ 984:
=== AXA Investor Relations | Keep in touch ===
* '''Roadshows''': March in Europe and US <sup>p. 29</sup>
* '''1Q25 Activity Indicators''': May 5 in Paris <sup>p. 29</sup>
* '''BNP Paribas Exane''' CEO Conference: June 2 in Paris <sup>p. 29</sup>
* '''Goldman Sachs European''' Financials Conference: June 2-4 in Zurich <sup>p. 29</sup>
* '''HY26 Earnings Release''': July 31 in Paris <sup>p. 29</sup>
* '''AXA Investor Day''': September 21 in London <sup>p. 29</sup>
* '''Investor Relations contact''': +33 1 40 75 48 42; investor.relations@axa.com <sup>p. 29</sup>
* '''Follow us''': www.axa.com <sup>p. 29</sup>
== Appendices ==
Line 870 ⟶ 997:
* Section divider slide marking the beginning of the '''Appendices''' section <sup>p. 30</sup>.
=== Table of contents ===
* '''
** 1. '''
** 2. Additional P&C disclosures <sup>p. 36</sup>
** 3. Additional IFRS17 disclosures <sup>p. 41</sup>
** 4. Sustainability <sup>p. 44</sup>
=== Gross financial debt and maturity breakdown as of December
* (stacked bar) '''Gross financial debt''' (nominal basis):
** '''FY24''': EUR 19.2bn total (Tier 1: EUR 4.8bn; Tier 2: EUR 10.8bn; Senior debt: EUR 3.5bn) <sup>p. 32</sup>
** '''
** '''
* '''Debt gearing''': 20.6% in FY24 to 22.3% in FY25 <sup>p. 32</sup>
* (stacked bar) '''Contractual maturity breakdown''':
** '''2028''': EUR 0.5bn (Senior debt) <sup>p. 32</sup>
** '''2030''': EUR 0.9bn total (Tier 2: EUR 0.7bn
*** '''o/w Grandfathered debt''': Tier 2: EUR 0.7bn <sup>p. 32</sup>
** '''2031-2039''': EUR 1.5bn (Senior debt) <sup>p. 32</sup>
** '''≥2040''': EUR 11.3bn total (Tier 2: EUR 10.8bn
*** '''o/w Grandfathered debt''': Tier 2: EUR 0.2bn <sup>p. 32</sup>
** '''Undated''': EUR 5.3bn total (Tier 1: EUR 4.6bn
*** '''o/w Grandfathered debt''': Tier 1: EUR 1.4bn <sup>p. 32</sup>
* (stacked bar) '''Economic maturity breakdown'''
** '''2026''': EUR 0.1bn (Tier 1) <sup>p. 32</sup>
*** '''o/w Grandfathered debt''': Tier 1: EUR 0.1bn <sup>p. 32</sup>
** '''2027''': EUR 2.4bn (Tier 2) <sup>p. 32</sup>
** '''2028''': EUR 0.6bn total (Tier 1: EUR 0.1bn
*** '''o/w Grandfathered debt''': Tier 1: EUR 0.1bn <sup>p. 32</sup>
** '''2029''': EUR 2.0bn (Tier 2) <sup>p. 32</sup>
** '''2030''': EUR 0.9bn total (Tier 2: EUR 0.7bn
*** '''o/w Grandfathered debt''': Tier 2: EUR 0.7bn <sup>p. 32</sup>
** '''2031-2039''': EUR
*** '''o/w Grandfathered debt''': Tier 1: EUR 0.4bn <sup>p. 32</sup>
** '''≥2040''': EUR 0.5bn (Senior debt) <sup>p. 32</sup>
*** '''o/w Grandfathered debt''': Tier 2: EUR 0.2bn <sup>p. 32</sup>
** '''Undated''': EUR 4.7bn total (Tier 1: EUR 4.0bn
*** '''o/w Grandfathered debt''': Tier 1: EUR 0.8bn <sup>p. 32</sup>
* '''Subsequent events''': In January 2026, AXA called the remaining Tier 2 grandfathered GBP 139m due 2054 callable 2034 (5.625% issued January 2014
* '''Economic maturity methodology''': Economic maturity takes into account the first date of step-up calls on institutionally placed subordinated debt; for Solvency II RT1 debt with no step-up, the undated nature of the instrument is retained <sup>p. 32</sup>.
=== General Account
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+
! style="text-align:left" | EUR billion unless otherwise mentioned
! class="col-s" style="text-align:right" |
! class="col-s" style="text-align:right" |
|-
| style="text-align:left" |
| style="text-align:right" |
| style="text-align:right" |
|-
| style="text-align:left" |
| style="text-align:right" |
| style="text-align:right" |
|-
| style="text-align:left" |
| style="text-align:right" |
| style="text-align:right" |
|-
| style="text-align:left" |
| style="text-align:right" |
| style="text-align:right" |
|-
| style="text-align:left" |
| style="text-align:right" |
| style="text-align:right" |
|-
| style="text-align:left" |
| style="text-align:right" |
| style="text-align:right" |
|-
| style="text-align:left
| style="text-align:right
| style="text-align:right
|-
| style="text-align:left" | Private equity and hedge funds
| style="text-align:right" | 23
| style="text-align:right" | 5%
|-
| style="text-align:left" | Cash
| style="text-align:right" | 19
| style="text-align:right" | 4%
|-
| style="text-align:left" | Policy loans
| style="text-align:right" | 2
| style="text-align:right" | 0%
|-
| style="text-align:left" | '''Total Insurance Invested Assets'''
| style="text-align:right" | '''450'''
| style="text-align:right" | '''100%'''
|}
</div>
*
* Duration gap at -0.4 year
* Invested assets portfolio breakdown (reported in EUR billion):
* Other fixed income includes Asset Backed Securities (EUR 25bn), Residential Loans (EUR 16bn), Commercial & Agricultural Loans (EUR 7bn), and Agency Pools (EUR 8bn)
* Listed equities includes hedges, with listed equities excluding hedges at EUR 14bn
* Private equity and hedge funds includes Private Equity (EUR 17bn), Hedge Funds (EUR 5bn), and Non-listed Equities (EUR 1bn)
=== Structured and Private Credit assets ===
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+
! style="text-align:left" |
! class="col-
! class="col-
|-
| style="text-align:left; font-weight:bold" | Total structured and private credit assets
|
|
|-
| style="text-align:left" |
|
|
|-
| style="text-align:left" |
|
|
|-
| style="text-align:left" |
|
|
|-
| style="text-align:left" |
|
|
|-
|
| style="text-align:right" | 10
| style="text-align:right" | 2%
|-
| style="text-align:left" | Other structured assets
| style="text-align:right" | 2
| style="text-align:right" | 0%
|}
</div>
* Total structured and private credit assets with 54% participating
* Residential mortgages:
* Includes EUR 6bn Dutch mortgages, NHG guaranteed.
* Includes EUR 10bn self-originated mortgages in Switzerland (56% LTV) and Germany (45% LTV).
* CLO & ABS: 91% senior CLOs with circa 40% subordination (100% rated AAA-A and 92% rated AAA-AA).
* Infrastructure debt: skewed towards resilient industries including telecom, utilities, and transport.
* CRE debt: showing strong sector diversification (mainly logistics, residential, and retail), mostly in Europe, and circa 60% LTV.
* Mid-market lending: featuring strong diversification with EUR 8m average ticket size; investments made through SMAs with strict underwriting guidelines (senior secured, covenants, restrictions on asset sales and sector allocation).
===
* '''Fixed income reinvestment''' totaled EUR 57bn in FY25 <sup>p. 35</sup>.
* (donut) '''FY25 Fixed Income Reinvestment''' asset allocation:
** Government bonds & related: 32% (average rating: AA) <sup>p. 35</sup>
** Investment grade credit: 40% (average rating: A) <sup>p. 35</sup>
** ABS/CLO/IG fund financing: 21% <sup>p. 35</sup>
** Below investment grade credit: 7% <sup>p. 35</sup>
* (bar) '''FY25 Fixed Income Reinvestment Yield''':
** Public fixed income (government and corporate bonds and related): 3.5% <sup>p. 35</sup>
** Private & Structured fixed income (CLOs, ABS, Infra & CRE debt, Fund financing and Private hybrid): 4.7% <sup>p. 35</sup>
** Total fixed income: 3.9% <sup>p. 35</sup>
* '''Reinvestment yield''' achieved at 3.9% on EUR 57bn invested <sup>p. 35</sup>:
** '''Average duration''' of 9 years <sup>p. 35</sup>
** Includes EUR 19.7bn of Private & Structured Credit invested at 4.7% (CLOs, ABS, Infra & CRE debt, Fund financing and Private HY) <sup>p. 35</sup>
** Gradual shift from alternative total return assets to Private & Structured credit <sup>p. 35</sup>
=== Table of contents ===
* '''Table of contents''' agenda overview:
** 1. Debt and Invested Assets <sup>p. 31</sup>
** '''2. Additional P&C disclosures''' (active section) <sup>p. 36</sup>
** 3. Additional IFRS17 disclosures <sup>p. 41</sup>
** 4. Sustainability <sup>p. 44</sup>
=== AXA XL Insurance | Large Commercial & Specialty business ===
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+
! style="text-align:left" |
! class="col-s" style="text-align:right" |
! class="col-s" style="text-align:right" |
|-
| style="text-align:left; font-weight:bold" |
| style="text-align:right; font-weight:bold" |
| style="text-align:right; font-weight:bold" |
|-
| style="text-align:
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Casualty
| style="text-align:right" | 35%
| style="text-align:right" | —
|-
| style="text-align:left" |
| style="text-align:right" |
| style="text-align:right" | —
|-
| style="text-align:left" | Specialty
| style="text-align:right" | 19%
| style="text-align:right" | —
|-
| style="text-align:left" | Professional lines (including Cyber)
| style="text-align:right" | 17%
| style="text-align:right" | —
|-
| style="text-align:left" |
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Americas
| style="text-align:right" | —
| style="text-align:right" | 46%
|-
| style="text-align:left" |
| style="text-align:right" | —
| style="text-align:right" | 35%
|-
| style="text-align:left" | UK & Lloyds
| style="text-align:right" | —
| style="text-align:right" |
|}
</div>
* '''AXA XL Insurance''' is well diversified across lines of business and geographies, holding leading market positions across lines.
* '''Leading market positions''' globally, ranking Top 3 in:
** Multinational Programs
** Marine
** Fine Art & Specie
* (bubble chart) '''Managing the cycle''' to deliver consistent profitability (Profitability vs Ex-price growth):
** '''Property''': High profitability, high ex-price growth
** '''Specialty''': Medium profitability, medium-high ex-price growth
** '''Casualty''': Medium-low profitability, medium ex-price growth
** '''Professional lines''': Low profitability, low ex-price growth
=== P&C | Focus on Reserves ===
* (bar chart) '''Claims reserves ratio''' (Net undiscounted claims reserves / Net earned premiums) <sup>p. 38</sup>:
** '''IFRS4''': FY18 179%, FY19 185%, FY20 193%, FY21 188%, FY22 189% <sup>p. 38</sup>
** '''IFRS17''': FY22 198%, FY23 195%, FY24 180%, FY25 175% <sup>p. 38</sup>
* (bar chart) '''Technical reserves ratio''' (Net undiscounted technical reserves / Net earned premiums) <sup>p. 38</sup>:
** '''IFRS4''': FY18 213%, FY19 227%, FY20 233%, FY21 226%, FY22 227% <sup>p. 38</sup>
** '''IFRS17''': FY22 234%, FY23 232%, FY24 216%, FY25 210% <sup>p. 38</sup>
* '''Technical reserves''' include net undiscounted claims reserves and unearned premium reserves <sup>p. 38</sup>.
=== P&C | 2026 Simplified Group Nat Cat Reinsurance Program 1 ===
Line 1,100 ⟶ 1,250:
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ Insurance segment (occurrence protection) capacity and retention by peril <sup>p. 39</sup>
! style="text-align:left" |
! class="col-s" style="text-align:right" | Capacity
! class="col-s" style="text-align:right" | Retention
|-
| style="text-align:left" | EU Windstorm
Line 1,125 ⟶ 1,275:
| style="text-align:right" | 600m
|-
| style="text-align:left" |
| style="text-align:right" | —
| style="text-align:right" | 400m
|}
</div>
* Retention levels remained stable in 2026 compared to 2025 <sup>p. 39</sup>.
* NA Hurricane: varying retention between EUR 400m MX and EUR 600m NA <sup>p. 39</sup>
* NA Earthquake: varying retention between EUR 400m MX and EUR 600m NA <sup>p. 39</sup>
* Per other perils: capacity varies by peril type; other perils include Turkey earthquake, Other Europe and NA perils, South America Earthquake, and other secondary perils <sup>p. 39</sup>
* (diagram) Reinsurance segment (illustrative) utilizes Alternative Capital & Cat Bonds <sup>p. 39</sup>.
=== P&C | AXA Group earnings deviation with different levels of Nat Cat cost 1 in 2026 ===
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ Group underlying earnings deviation to average Nat Cat charges in 2026
! style="text-align:left" | Percentile
! class="col-s" style="text-align:right" |
|-
| style="text-align:left" |
| style="text-align:right" | -1.2
|-
| style="text-align:left" |
| style="text-align:right" | -0.8
|-
| style="text-align:left" |
| style="text-align:right" | -0.4
|-
| style="text-align:left" |
| style="text-align:right" | +0.1
|-
| style="text-align:left" |
| style="text-align:right" | +0.5
|-
| style="text-align:left" |
| style="text-align:right" | +0.7
|-
| style="text-align:left" |
| style="text-align:right" | +0.8
|}
Line 1,169 ⟶ 1,320:
{| class="wikitable"
|+ Average expected Nat Cat charges net of reinsurance, pre-tax <sup>p. 40</sup>
! style="text-align:left" |
! class="col-
! class="col-
|-
| style="text-align:left" |
| class="col-
| class="col-
|-
| style="text-align:left" |
| class="col-
| class="col-
|}
</div>
* Earnings deviation basis: Group underlying earnings deviation to average Nat Cat charges in 2026 net of reinsurance, post-tax, in EUR billion <sup>p. 40</sup>.
* More severe years (negative deviation in ca. 40% of cases) <sup>p. 40</sup>:
* Less severe years (positive deviation in ca. 60% of cases) <sup>p. 40</sup>:
* Nat Cat definition: Natural catastrophe cost defined as Aggregate Exceedance Probability (AEP) of all natural perils worldwide, net of tax and reinsurance <sup>p. 40</sup>.
* Deviation baseline: Deviation is compared to a normalized level, which are costs associated with natural catastrophes expected in an average year, representing ca. 4.5 points of estimated FY25 GEP, undiscounted and net of reinsurance <sup>p. 40</sup>.
=== Table of contents ===
* '''Table of contents''' section divider <sup>p. 41</sup>:
** 1. Debt and Invested Assets <sup>p. 31</sup>
** '''3. Additional IFRS17 disclosures''' <sup>p. 41</sup>
** 4. Sustainability <sup>p. 44</sup>
=== P&C | Margin
* (flow) '''P&C Margin Analysis''' (in EUR million pre-tax, changes versus FY24 at constant FX) <sup>p. 42</sup>:
** '''Technical Result''' components:
**** Gross Earned Premiums: EUR 57,656m (+6%) <sup>p. 42</sup>
**** Current Accident Year Undiscounted Combined Ratio: 95.2% (-1.0pt) <sup>p. 42</sup>
**** ''o/w Nat Cats'': 3.4% (-0.4pt) <sup>p. 42</sup>
*** '''Current Accident Year Discounting''': EUR 2,009m (change: +EUR 115m) <sup>p. 42</sup>
**** Discounting Ratio (in Combined Ratio points): -3.5% (+0.0pt) <sup>p. 42</sup>
**** Current Accident Year Net Claims reserves: EUR 19.0bn <sup>p. 42</sup>
**** Duration: 4.0 years <sup>p. 42</sup>
**** Current Accident Year Discount rate: 2.8% <sup>p. 42</sup>
*** '''Prior Years' Reserve Development (PYD)''': EUR 622m (change: -EUR 341m) <sup>p. 42</sup>
**** PYD ratio: -1.1% (+0.7pt) <sup>p. 42</sup>
** '''Financial Result''' components:
*** '''Investment Income''': EUR 3,988m (change: +EUR 435m) <sup>p. 42</sup>
**** FY25 Average Assets: EUR 115bn <sup>p. 42</sup>
**** Asset book yield: 3.5% <sup>p. 42</sup>
**** FY25 Reinvestment yield (on fixed income assets): 4.3% <sup>p. 42</sup>
*** '''Insurance Finance Expenses''': -EUR 1,358m (change: -EUR 235m) <sup>p. 42</sup>
**** FY24 Reserves at locked-in rate: EUR 71bn <sup>p. 42</sup>
**** Liability book yield: 1.9% <sup>p. 42</sup>
** '''Underlying Earnings before tax''': EUR 8,040m (change: +EUR 681m) <sup>p. 42</sup>
*** Tax: -EUR 2,060m (change: -EUR 169m) <sup>p. 42</sup>
*** Affiliates, Minority interests & Other: -EUR 108m (change: -EUR 10m) <sup>p. 42</sup>
*** '''Underlying Earnings''': EUR 5,872m (change: +EUR 501m, +9% growth vs. FY24 at constant FX) <sup>p. 42</sup>
* '''FY25 sensitivity''' to Current Accident Year discount rate changes (parallel shift of the full-year average yield curve used for discounting FY25 current accident year net reserve) <sup>p. 42</sup>:
** +25bps: +EUR 0.2bn <sup>p. 42</sup>
** -25bps: -EUR 0.2bn <sup>p. 42</sup>
* '''2026e Insurance Finance Expenses''' (pre-tax): ~ -EUR 1.4bn <sup>p. 42</sup>
** Sensitivity of 2026e Insurance Finance Expenses to changes in 2025 current AY Discount <sup>p. 42</sup>:
*** +25bps: ~ -EUR 50m <sup>p. 42</sup>
*** -25bps: ~ +EUR 50m <sup>p. 42</sup>
=== L&H | Margin Analysis ===
* '''L&H Margin Analysis''' includes scope impact; changes are versus FY24 at constant FX <sup>p. 43</sup>.
=== Technical Result (in EUR million, pre-tax) ===
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+
! style="text-align:left" | EUR million unless otherwise mentioned
! class="col-s" style="text-align:right" | FY25
! class="col-
|-
| style="text-align:left" | Short-term Technical Margin
Line 1,354 ⟶ 1,399:
| style="text-align:right" | +60
|-
| style="text-align:left" | Gross
| style="text-align:right" | 17,416
| style="text-align:right" | +10%
|-
| style="text-align:left" | Combined
| style="text-align:right" | 97.2%
| style="text-align:right" |
|-
| style="text-align:left" | Long-term Technical Margin
Line 1,373 ⟶ 1,418:
| style="text-align:right" | -150
| style="text-align:right" | -58
|}
</div>
* Short-term Technical Margin includes the recapture of Laya.
=== Financial Result (in EUR million, pre-tax) ===
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ Investment Income and Insurance Finance Expenses, non-VFA <sup>p. 43</sup>
! style="text-align:left" | EUR million
! class="col-s" style="text-align:right" | Value
! class="col-s" style="text-align:right" | Change
|-
| style="text-align:left" | Investment Income
| style="text-align:right" | 2,484
| style="text-align:right" | -1
|-
| style="text-align:left" | Insurance Finance Expenses
| style="text-align:right" | -1,538
| style="text-align:right" | -9
|
</div>
* Average Assets (FY25) were EUR 98bn.
* Asset book yield was 2.5%.
* Reinvestment yield (FY25 on fixed income assets) was 3.8%.
* Reserves at locked-in rate (FY24) were EUR 62bn.
* Liability book yield was 2.5%.
=== Earnings Bridge ===
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ Underlying Earnings walk <sup>p. 43</sup>
! style="text-align:left" | EUR million
! class="col-s" style="text-align:right" | Value
! class="col-s" style="text-align:right" | Change
|-
| style="text-align:left" | Underlying Earnings before tax
Line 1,410 ⟶ 1,463:
| style="text-align:right" | +65
|-
| style="text-align:left" | Affiliates and minorities (including other)
| style="text-align:right" | 72
| style="text-align:right" | -51
Line 1,419 ⟶ 1,472:
|}
</div>
* Underlying Earnings represents +7% growth versus FY24 at constant FX.
=== Life & Health FY25 CSM Key Sensitivities (in EUR billion) ===
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+
! style="text-align:left" |
! class="col-s" style="text-align:right" |
! class="col-s" style="text-align:right" | -50bps / -25%
|-
| style="text-align:left" |
| style="text-align:right" | 33.3
| style="text-align:right" | —
|-
| style="text-align:left" | Interest
| style="text-align:right" | -0.8
| style="text-align:right" | +0.6
|-
| style="text-align:left" | Sovereign
| style="text-align:right" | -1.9
| style="text-align:right" | +1.9
|-
| style="text-align:left" | Corporate spread
| style="text-align:right" | -0.8
| style="text-align:right" | +0.7
|-
| style="text-align:left" |
| style="text-align:right" | +1.8
| style="text-align:right" | -2.2
|}
</div>
* '''Table of contents''' section navigation:
** 1. Debt and Invested Assets <sup>p. 31</sup>
** 2. Additional P&C disclosures <sup>p. 36</sup>
Line 1,466 ⟶ 1,515:
=== Expanding AXA's role in society: AXA for Progress Index 1 ===
<div style="overflow-x:auto">
{| class="wikitable"
|+ AXA for Progress Index performance dashboard <sup>p. 45</sup>
! style="text-align:left" | Pillar
! class="col-m" style="text-align:right" | Metric
! class="col-m" style="text-align:right" | Target
! class="col-m" style="text-align:right" | 2025 Result
|-
| style="text-align:left" | Global Investor
| class="col-m" style="text-align:right" | Climate transition financing
| class="col-m" style="text-align:right" | EUR 5.0bn per year
| class="col-m" style="text-align:right" | EUR 6.4bn
| style="text-align:left" | Global Investor
| class="col-m" style="text-align:right" | Community resilience financing
| class="col-m" style="text-align:right" | >EUR 500m per year
| class="col-m" style="text-align:right" | EUR 1.4bn
|-
| style="text-align:left" | Global Insurer
| class="col-m" style="text-align:right" | Transition underwriting
| class="col-m" style="text-align:right" | EUR 6.0bn in P&C GWP (cumulative 2024-2026)
| class="col-m" style="text-align:right" | EUR 4.6bn
|-
| style="text-align:left" | Global Insurer
| class="col-m" style="text-align:right" | Climate adaptation solutions
| class="col-m" style="text-align:right" | >20,000 (cumulative 2024-2026)
| class="col-m" style="text-align:right" | 19,698
|-
| style="text-align:left" | Global Insurer
| class="col-m" style="text-align:right" | Inclusive insurance customers
| class="col-m" style="text-align:right" | >20m by 2026
| class="col-m" style="text-align:right" | 20.6m
|-
| style="text-align:left" | Company
| class="col-m" style="text-align:right" | Employee climate training
| class="col-m" style="text-align:right" | >80,000 by 2026
| class="col-m" style="text-align:right" | 46,420
|-
| style="text-align:left" | Company
| class="col-m" style="text-align:right" | Net-Zero contribution
| class="col-m" style="text-align:right" | -50% absolute carbon emissions by 2030
| class="col-m" style="text-align:right" | -64% reduction against 2019
|-
| style="text-align:left" | Company
| class="col-m" style="text-align:right" | Employee volunteering
| class="col-m" style="text-align:right" | 50% of employees by 2026
| class="col-m" style="text-align:right" | 56%
|}
</div>
* '''AXA for Progress Index''' performance dashboard across three pillars: Global Investor, Global Insurer, and Company <sup>p. 45</sup>.
* '''Climate adaptation solutions''': Target of >20,000 climate adaptation solutions & services (cumulative 2024-2026; target revised in 2025 from >9,000) vs. 19,698 cumulative 2024-2025 result <sup>p. 45</sup>.
* '''Net-Zero contribution''': Target of -50% absolute carbon emissions by 2030 (scope: energy Scopes 1 and 2, car fleet, and business travel; baseline 2019) and offset of residual emissions via nature-based or technical carbon capture projects vs. -64% reduction against 2019 in 2025 <sup>p. 45</sup>.
=== Sustainability Performance & Ratings ===
Line 1,492 ⟶ 1,572:
<div style="overflow-x:auto">
{| class="wikitable"
|+
! style="text-align:left" | Rating Agency
! class="col-m" style="text-align:right" | 2025 Score
|-
| style="text-align:left" | S&P Global
| class="col-m" style="text-align:right" | 97th percentile
|-
| style="text-align:left" | MSCI
Line 1,509 ⟶ 1,589:
|-
| style="text-align:left" | FTSE Russell
| class="col-m" style="text-align:right" | 4.3/5
|}
</div>
* CSA ranking is a key performance indicator for AXA Group, used to calculate the grant of Long-Term Incentives (specifically AXA Restricted Shares), with results as of February 6th, 2026
* '''FTSE Russell''' 2025 score: 4.3/5 in FTSE4Good Index Series <sup>p. 46</sup>
=== Scope ===
* '''France''' scope includes insurance activities, banking activities, and holding <sup>p. 47</sup>.
* '''Europe''' scope includes Switzerland (insurance
* '''AXA XL''' scope includes insurance and reinsurance activities and holding <sup>p. 47</sup>.
* '''Asia, Africa & EME-LATAM''' scope includes:
** '''Asia''': Japan (insurance
** '''Africa''': Morocco (insurance
** '''EME-LATAM''': Mexico (insurance
** '''AXA Mediterranean Holdings''' <sup>p. 47</sup>.
* '''Transversal & Other''' scope includes AXA Assistance, AXA Liabilities Managers, AXA, and other Central Holdings <sup>p. 47</sup>.
* '''AXA Investment Managers''' (until July 1, 2025) scope includes AXA Investment Managers, Select (previously referred to as Architas), and Capza (all fully consolidated), and Asian joint ventures (consolidated under equity method
* '''Accounting standards''' note:
=== Glossary ===
Line 1,545 ⟶ 1,625:
* '''Underlying return on in-force''': represents the release of Time Value of Options & Guarantees (TVOG) plus the unwind of CSM at the reference rate plus the underlying financial over-performance <sup>p. 48</sup>
=== February 26, 2026 Thank you Full Year 2025
*
* '''Presentation title''': Full Year 2025 Earnings <sup>p. 49</sup>.
* '''Presentation date''': February 26, 2026 <sup>p. 49</sup>.
== Abbreviations ==
* '''AA''':
* '''AAA''':
* '''ABS''': Asset-Backed Securities
* '''AEP''': Aggregate Exceedance Probability
* '''AI''': Artificial Intelligence
* '''APAC''': Asia-Pacific
* '''APM''': Alternative Performance Measures
* '''AXA IM''': AXA Investment Managers
* '''AXA
* '''AY''': Accident Year
* '''BBA''':
* '''CDP''': Carbon Disclosure Project
* '''CLO''': Collateralized Loan Obligation
Line 1,568 ⟶ 1,650:
* '''CSM''': Contractual Service Margin
* '''CY''': Calendar Year
* '''DPS''':
* '''EME''':
* '''EOF''': Eligible Own Funds
* '''EPS''': Earnings Per Share
Line 1,575 ⟶ 1,657:
* '''EU''': European Union
* '''EUR''': Euro
* '''FTSE''': Financial Times Stock Exchange
* '''FX''': Foreign Exchange
* '''GAAP''': Generally Accepted Accounting Principles
* '''GEP''': Gross Earned Premium
* '''GWP''': Gross Written Premiums
* '''HKD''': Hong Kong Dollar
* '''HY''': High Yield
* '''IFE''': Insurance Finance Expenses
* '''IFRS''': International Financial Reporting Standards
Line 1,589 ⟶ 1,672:
* '''LTV''': Loan-to-Value
* '''MSCI''': Morgan Stanley Capital International
* '''MX''': Mexico
* '''NA''': North America
* '''NB CSM''': New Business Contractual Service Margin
* '''NBV''': New Business Value
* '''NHG''': Nationale Hypotheek Garantie
* '''NPS''': Net Promoter Score
* '''OCI''': Other Comprehensive Income
* '''PAA''':
* '''PE''': Private Equity
* '''PVEP''': Present Value of Expected Profits
* '''PYD''': Prior Years' Reserve Development
* '''RCG''':
* '''ROE''': Return on Equity
* '''SCR''': Solvency Capital Requirement
Line 1,610 ⟶ 1,694:
* '''USD''': United States Dollar
* '''VAT''': Value Added Tax
* '''VFA''': Volatility Adjustment
| |||